Medication-Induced Movement
Substance-Related
Full criteria not included in this record
Full criteria not included in this record
Full criteria not included in this record
Full criteria not included in this record
A. Subjective complaints of restlessness after exposure to medication B. At least one of: fidgety movements; rocking from foot to foot; pacing; inability to sit or stand still for at least several minutes C. Onset of symptoms within 4 weeks of initiating or increasing dose of causative medication, or after reducing medication used to treat EPS
A. Intoxication: recent stimulant use; Withdrawal: cessation/reduction after prolonged heavy use B. Intoxication: clinically significant maladaptive behavioural/psychological changes + ≥2 of: tachycardia/bradycardia; pupillary dilation; elevated/lowered BP; sweating/chills; nausea/vomiting; weight loss; psychomotor agitation/retardation; muscular weakness; chest pain; arrhythmia; confusion; seizures/dyskinesias/dystonias; coma; Withdrawal: dysphoric mood + ≥2 of: fatigue; vivid unpleasant dreams; insomnia/hypersomnia; increased appetite; psychomotor retardation/agitation C. Not attributable to another medical condition or better explained by another mental disorder or substance
Mild; Moderate; Severe
With perceptual disturbances (intoxication); Stimulant use disorder - Mild / Moderate / Severe; Specify stimulant
Anxiety disorder (no clear temporal link to medication; no motor restlessness); Psychotic agitation (goal-directed motor activity; may coexist - worsening ‘agitation' on antipsychotics may be akathisia); Restless legs syndrome (circadian pattern; sensory; at rest; relieved by movement; sleep-associated)
Intoxication: primary mania, schizophrenia, thyrotoxicosis, phaeochromocytoma, hallucinogen intoxication; Withdrawal: primary MDD, hypothyroidism, excessive sleep disorder